COVID-19 Booster for Children Ages 5-11 in Laredo

Translate to Spanish or other 102 languages!

 The U.S. Food and Drug Administration authorized a single booster of the Pfizer-BioNTech COVID-19 vaccine for individuals 5 through 11 years of age at least five months after completion of their primary series. Image for illustration purposes
The U.S. Food and Drug Administration authorized a single booster of the Pfizer-BioNTech COVID-19 vaccine for individuals 5 through 11 years of age at least five months after completion of their primary series. Image for illustration purposes

Mega Doctor News

- Advertisement -

LAREDO, Texas – The U.S. Food and Drug Administration authorized a single booster of the Pfizer-BioNTech COVID-19 vaccine for individuals 5 through 11 years of age at least five months after completion of their primary series. 

Pfizer’s clinical trial showed that a booster dose of the Pfizer-BioNTech COVID-19 Vaccine prompted a robust immune response in this age group, generating neutralizing antibodies against the SARS-CoV-2 virus regardless of prior SARS-CoV-2 infection. The actions taken by the FDA would make all Americans 5 and older eligible for a booster shot.

“FDA/CDC pediatric booster approval ensures a higher level of COVID-19 protection amongst children over the summer and when returning to school in the fall,” says Dr. Richard Chamberlain, Health Director, “We continue to urge our community to get vaccinated; vaccines work, vaccines are safe, and vaccines save lives. Stay up-to-date with your vaccines”.

- Advertisement -

The City of Laredo Health Department will provide COVID-19 boosters shots to children 5-11 years of age starting Friday, May 20, 2022. Vaccines will be available at the City of Laredo Health Department Clinic located at 2600 Cedar Ave. or across the city of Laredo via our Mobile Health Clinic

For more information or updates, please follow our social media channels at @LaredoHealth or call (956) 236-8311.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -